Intraoperative detection of somatostatin-receptor-positive neuroendocrine tumours using indium-111-labelled DTPA-D-Phel-octreotide
1996

Intraoperative Detection of Neuroendocrine Tumors Using Indium-111 Octreotide

Sample size: 23 publication Evidence: moderate

Author Information

Author(s): B Wangberg, E Forssell-Aronsson, L-E Tisell, O Nilsson, M Fjalling, H Ahlman

Primary Institution: Sahlgrenska Hospital, Gothenburg, Sweden

Hypothesis

Can intraoperative scintillation detection improve the localization of somatostatin-receptor-positive neuroendocrine tumors?

Conclusion

Intraoperative measurements using a scintillation detector provided more reliable results than in situ measurements for detecting neuroendocrine tumors.

Supporting Evidence

  • All patients with midgut carcinoids had positive preoperative scintigraphy.
  • False results were found in both in situ and ex vivo measurements for some tumors.
  • T/B ratios varied significantly between different tumor types, indicating varying detection efficacy.

Takeaway

Doctors used a special camera to find tumors during surgery, and it worked better after the tumors were taken out than while they were still in the body.

Methodology

Patients received an injection of indium-111 octreotide before surgery, and tumor localization was assessed using a scintillation detector during the operation.

Limitations

In situ measurements often gave misleading results, and the technique may underestimate the activity concentration of small tumors.

Participant Demographics

Patients included those with midgut carcinoids, medullary thyroid carcinomas, and other neuroendocrine tumors.

Statistical Information

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication